Hepatitis
Conference Coverage
HCC rates slow in cities, continue to climb in rural areas
Disparities in hepatocellular carcinoma incidence rates between urban and rural areas vary by race/ethnicity.
Conference Coverage
Harnessing the HIV care continuum model to improve HCV treatment success
Substance use, trauma histories, and mental health problems can negatively affect HCV care engagement.
From the Journals
Opt-out policy at a syringe service program increased HIV/HCV testing
For HIV and HCV among people who inject drugs, it is important to improve diagnosis and linkage to care.
Opinion
Direct-acting agents cure hepatitis C in children
There now are three direct-acting antiviral agents available to treat HCV in children.
Conference Coverage
Hepatocellular carcinoma shows risk factor shift
Demographics, obesity, and metabolic factors have emerged as main drivers of disease.
Conference Coverage
Many advanced countries missing targets for HCV elimination
“In the countries making progress, the common elements are political will, a clear national plan, and easing of restrictions on the cascade of...
From the Journals
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
News
New CDC guidance for health care personnel exposed to HCV
Baseline testing of the source patient and the HCP should be performed as soon as possible, preferably within 48 hours of exposure.
Conference Coverage
Hep C sofosbuvir/daclatasvir combo promising for COVID-19
“We need to remember that conducting research amidst a pandemic with overwhelmed hospitals is a clear challenge, and we cannot be sure of success...
News
Nucleoside polymers show early promise in HBV
For patients with chronic HBV infection, triple-combination therapy with tenofovir disoproxil fumarate, pegylated interferon alfa-2a (TDF-pegIFN...
News
CDC: Screen nearly all adults, including pregnant women, for HCV